Molecular identification of amino acid sensor and its function in mTORC1 signaling pathway
Project/Area Number |
15K08273
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
General medical chemistry
|
Research Institution | Osaka University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
中込 咲綾 大阪大学, 医学(系)研究科(研究院), その他 (60423894)
|
Co-Investigator(Renkei-kenkyūsha) |
OKUDA SUGURU 大阪大学, 大学院医学系研究科, 助教 (50511846)
NAGAMORI SHUSHI 大阪大学, 大学院医学系研究科, 准教授 (90467572)
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2016: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2015: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Keywords | アミノ酸 / mTORC1 / シグナル伝達 / 細胞内シグナル伝達 / 受容体 |
Outline of Final Research Achievements |
Amino acids play an important role as signaling molecules to activate mTORC1, a serine/threonine kinase complex which regulates cellular metabolism. However, the detailed molecular mechanisms of amino acid sensing still remain elusive. In this study, we have tried to understand the molecular basis of amino acids sensing in the upstream of mTORC1, especially focusing on how the cells recognize the extracellular amino acids. The experimental protocol for the comparative proteomics analysis using the plasma membrane fractions has been established. Also, the conditions of cell treatments as well as the methods for detection of mTORC1 activity were optimized, to improve the reliability and the throughput of the analyses. The outcomes the research would significantly contribute to identifying the amino acid sensing molecules in the future studies.
|
Report
(4 results)
Research Products
(38 results)
-
-
-
-
[Journal Article] Interaction of the Sodium/Glucose Cotransporter (SGLT) 2 inhibitor Canagliflozin with SGLT1 and SGLT2: Inhibition kinetics, sidedness of action, and transporter-associated incorporation accounting for its pharmacodynamic and pharmacokinetic features.2016
Author(s)
Ohgaki R, Wei L, Yamada K, Hara T, Kuriyama C, Okuda S, Ueta K, Shiotani M, Nagamori S, Kanai Y.
-
Journal Title
J Pharmacol Exp Ther.
Volume: 358
Issue: 1
Pages: 94-102
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
[Journal Article] Impaired Amino Acid Transport at the Blood Brain Barrier Is a Cause of Autism Spectrum Disorder.2016
Author(s)
Tarlungeanu DC, Deliu E, Dotter CP, Kara M, Janiesch PC, Scalise M, Galluccio M, Tesulov M, Morelli E, Sonmez FM, Bilguvar K, Ohgaki R, Kanai Y, Johansen A, Esharif S, Ben-Omran T, Topcu M, Schlessinger A, Indiveri C, Duncan KE, Caglayan AO, Gunel M, Gleeson JG, Novarino G.
-
Journal Title
Cell.
Volume: 167
Issue: 6
Pages: 1481-1494
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
[Journal Article] Transport of 3-fluoro-l-α-methyl-tyrosine (FAMT) by organic ion transporters explains renal background in [(18)F]FAMT positron emission tomography.2016
Author(s)
Wei L, Tominaga H, Ohgaki R, Wiriyasermkul P, Hagiwara K, Okuda S, Kaira K, Kato Y, Oriuchi N, Nagamori S, Kanai Y.
-
Journal Title
J Pharmacol Sci.
Volume: 130
Issue: 2
Pages: 101-109
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
-
-
[Journal Article] Novel cystine transporter in renal proximal tubule identified as a missing partner of cystinuria-related plasma membrane protein rBAT/SLC3A1.2016
Author(s)
Nagamori S, Wiriyasermkul P, Guarch ME, Okuyama H, Nakagomi S, Tadagaki K, Nishinaka Y, Bodoy S, Takafuji K, Okuda S, Kurokawa J, Ohgaki R, Nunes V, Palacín M, Kanai Y.
-
Journal Title
Proc Natl Acad Sci U S A.
Volume: 113
Issue: 3
Pages: 775-780
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Inhibition kinetics, sidedness of action, and transporter-mediated uptake of the sodium/glucose cotransporter (SGLT) 2 inhibitor canagliflozin: implications for its pharmacodynamic and pharmacokinetic features2016
Author(s)
Ohgaki R, Wei L, Yamada K, Hara T, Kuriyama C, Okuda S, Ueta K, Leclercq L, Mamidi RN, Shiotani M, Nagamori S, Kanai Y
Organizer
76th American Diabetes Association Scientific Sessions
Place of Presentation
New Orleans, Louisiana, US
Year and Date
2016-06-10
Related Report
Int'l Joint Research
-
-
-
-
-
[Presentation] Inhibition kinetics, sidedness of action, and transporter-mediated uptake of the sodium/glucose cotransporter (SGLT) 2 inhibitor canagliflozin: implications for its pharmacodynamic and pharmacokinetic features2016
Author(s)
Ling Wei, Ryuichi Ohgaki, Kazunori Yamada, Taiki Hara, Chiaki Kuriyama, Suguru Okuda, Kiichiro Ueta, Masaharu shiotani, Shushi Nagamori and Yoshikatsu Kanai
Organizer
International and Interdisciplinary Symposium 2016 “Towards a New Era of Cardiovascular Research”
Place of Presentation
東京
Related Report
-
-
-
-
-
-
-
-
-
-